Inogen announces preliminary, unaudited full year and fourth quarter 2021 revenue results

Goleta, calif.--(business wire)--inogen, inc. (nasdaq: ingn), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported preliminary, unaudited revenue results for the three-month and twelve-month periods ended december 31, 2021. preliminary unaudited revenue summary: total full year 2021 revenue is expected to be in the range of $357.5 to $358.5 million based on preliminary, unaudited financial data, up 15.9% to 16.2% from 2020 total f
INGN Ratings Summary
INGN Quant Ranking